Respiratory ward II

【Growth Process】

On March 28, 2018, the Second Respiratory Ward was officially established with 24 open beds. In April 2018, the department’s first fiberoptic bronchoscopy and bronchoscopy lung tumor biopsy were performed. (Main developer: Zhao Dejun) In May 2018, the first case of non-invasive ventilator-assisted ventilation was carried out, and the patient with respiratory failure has benefited so far. (Main conductor: Zhao Dejun) In May 2018, the first bronchoscopy lung biopsy was performed (Main conductor: Zhao Dejun) In May 2018, the first severe pneumonia patient was admitted and good results were achieved June 2018 , the first joint radiotherapy department to perform radiotherapy for lung cancer patients. In July 2018, the first CT-guided lung biopsy was performed (main performer: Zhao Dejun). In August 2018, 10 patients with gas poisoning were treated for the first time. Since then, There are 34 open beds. In October 2018, the first combined vascular surgery interventional treatment was performed on a patient with massive hemoptysis (main developer: Zhao Dejun). In December 2018, the first patient with invasive mechanical ventilation was managed (main developer: Zhao Dejun) In January 2019, the first patient with severe sleep apnea was admitted. In February 2019, 36 beds were opened. In March 2019, a doctoral workstation was established in conjunction with Shaw Hospital affiliated to Zhejiang University School of Medicine. External doctor: Chen Enguo was hired. In May 2019, the first workstation was launched. A case of deep venous puncture catheterization (main performer: Wang Xia) In June 2019, for the first time, thrombectomy was performed on a patient with pulmonary embolism in conjunction with vascular surgery. In July 2019, for the first time, bronchoscopy was performed on a patient with lung cancer to detect airway tumors. Debridement and tracheoscopic stent placement (main developer: Zhao Dejun) From 2020.01 to 2020.06, the entire department was on the front line of the fight against the new coronavirus pneumonia. The department restarted on June 22, 2020. In July 2022, the respiratory interventional diagnosis and treatment center (center Director: Zhao Dejun) In July 2022, medical thoracoscopic surgery was performed for the first time (main performer: Zhao Dejun) In October 2022, tracheal balloon dilatation was performed for the first time (main performer: Zhao Dejun) In February 2023, for the first time Carry out ultrasound EBUS-TBLB (main conductor: Zhao Dejun) In May 2023, conduct EBUS-TBNA for the first time (main conductor: Zhao Dejun)

[Successively served as diagnosis and treatment team leader, director, and head nurse]

In March 2018, department director Zhao Dejun and head nurse Xu Lili led the hospital's medical elite to build the department and create the second respiratory ward from scratch. In June 2020, department director Zhao Dejun and head nurse Qiu Yiping led the medical staff of the department to restart the second respiratory ward during the COVID-19 fight, bringing good news to patients in the respiratory department. In February 2023, department director Zhao Dejun and head nurse Yu Jiajia led the medical staff of the department to move the department to the fourth floor of the infection building, adding new color to the construction of the department

【Current status of subject】

The Second Respiratory Ward was established in 2018. Deputy Chief Doctor Zhao Dejun serves as the department director and Yu Jiajia serves as the head nurse. Currently, the Respiratory Ward No. 2 has 9 doctors, including 2 deputy chief physicians, 3 attending physicians, and 4 residents, including 4 master's degree students. They are responsible for 7 ongoing and completed research projects and have published 10 papers in core domestic journals. Yu Pian is a united, pragmatic, enterprising and diligent medical team. The department is equipped with a fiberoptic bronchoscopy room, pulmonary function room, non-invasive ventilator, high-flow, etc., with 36 approved beds and an outpatient volume of 25,000. The department specializes in treating chronic obstructive pulmonary diseases (including chronic bronchitis, emphysema), severe bronchial asthma, pulmonary infectious diseases, cor pulmonale, pulmonary embolism, pleural diseases (pneumothorax, pleural effusion), acute and chronic respiratory failure, We have accumulated rich experience in the diagnosis and treatment of interstitial pulmonary diseases, lung tumors, hemoptysis, and unexplained fever. We carry out fiberoptic bronchoscopy diagnosis and treatment, non-invasive ventilator-assisted ventilation, airway responsiveness measurement, and CT-guided pulmonary Puncture biopsy, bronchial artery embolization, radiotherapy, chemotherapy and targeted therapy for lung cancer, and immunotherapy, the diagnosis and treatment level is in a leading position in Fuyang area. The department currently has 9 doctors, including 2 deputy chief physicians: Zhao Dejun and Wang Xia, 3 attending physicians: Hu Danping, Zhang Bingxin, and Zhu Huilin, and 4 resident physicians: Yan Jinnong, Chen Qian, Guo Feiyan, and Li Xiaolan. There are 15 nurses: Yu Jiajia, Sun Jingbo, Ye Xiaofen, Lan Dufei, Zhou Dan, Zhu Lei, Yu Yilan, Wang Fengyan, Qi Jiajia, Li Chenpiao, Wang Xumin, Chen Liu, Yu Guannan, Lu Danping, Zhu Jiuhong

【Diagnosis and treatment scope】

Various infectious diseases: common cold, influenza, various chronic coughs, acute and chronic bronchitis, various pneumonias, fungal infections, lung abscess, empyema, etc. Lung tumors, airflow obstructive diseases, including chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis, etc. Respiratory system critical illness: respiratory failure, acute respiratory distress syndrome, severe asthma, hemoptysis treatment. Pleural diseases, including pneumothorax, pleural effusion, etc., ventilation regulation dysfunction diseases, sleep disordered breathing syndrome, hyperventilation syndrome, diffuse lung disease, and interstitial lung disease. Other lung diseases: Diagnosis and treatment of pulmonary complications of toxic gas inhalation, respiratory amyloidosis, alveolar microlithiasis, immobile ciliary syndrome, and pulmonary sequestration.

【Technical Features】

The department is equipped with non-invasive ventilator, external defibrillator, fiberoptic bronchoscopy room, new electric monitor, pulmonary function room, etc. Responsible for the treatment of patients in the respiratory department throughout Fuyang District and surrounding areas, it routinely performs non-invasive mechanical ventilation, fiberoptic bronchoscopy, bronchoscopy lung biopsy, bronchoscopy bronchial biopsy, bronchoalveolar lavage, and CT-guided lung puncture Biopsy, deep venous puncture and catheterization, bronchoscopy stent implantation, bronchial artery embolization, etc. It can provide comprehensive diagnosis and treatment for respiratory patients, such as: 1. Diagnosis of patients with lung malignant tumors; 2. Standardized treatment of intermediate and advanced lung cancer, including chemotherapy, targeted therapy, and immunotherapy; 3. Non-invasive/invasive treatment of patients with respiratory failure Ventilation; 4. Standardized management of pulmonary nodules; 5. Standardized management of chronic diseases, such as chronic obstructive pulmonary disease, bronchial asthma, and interstitial lung disease, and gradually formed a system for the treatment of respiratory failure, pulmonary embolism, acute lung injury, and multiple The professional characteristics of diseases such as organ failure have made outstanding contributions in the diagnosis and treatment of various common respiratory diseases, frequently-occurring diseases, chronic cough, bronchial asthma, severe pneumonia, lung malignant tumors, etc.

【Scientific research results】

The department has a doctoral clinical research work site, established and completed 7 provincial and municipal level projects, and published 5 Chinese series and SCI papers.